Total Payments
$3,477
2024 Payments
$122.87
Companies
32
Transactions
183
Medicare Patients
6,478
Medicare Billing
$677,097
Payment Breakdown by Category
Food & Beverage$3,267 (94.0%)
Education$209.10 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,267 | 179 | 94.0% |
| Education | $209.10 | 4 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $384.89 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $367.68 | 23 | $0 (2022) |
| Boston Scientific Corporation | $319.49 | 21 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $270.75 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $237.37 | 14 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $205.61 | 11 | $0 (2022) |
| Astellas Pharma US Inc | $198.00 | 2 | $0 (2021) |
| Abbott Laboratories | $176.72 | 6 | $0 (2024) |
| Amgen Inc. | $173.18 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $167.16 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.87 | 4 | Impulse Dynamics (USA) Inc. ($51.52) |
| 2023 | $777.35 | 38 | PFIZER INC. ($195.72) |
| 2022 | $491.46 | 33 | Boston Scientific Corporation ($168.14) |
| 2021 | $412.11 | 13 | Astellas Pharma US Inc ($198.00) |
| 2020 | $190.91 | 11 | AstraZeneca Pharmaceuticals LP ($85.00) |
| 2019 | $426.36 | 19 | Boston Scientific Corporation ($88.93) |
| 2018 | $386.91 | 23 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($154.53) |
| 2017 | $668.60 | 42 | AstraZeneca Pharmaceuticals LP ($115.93) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $34.78 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Heart Failure | ||||||
| 01/30/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $51.52 | General |
| Category: Cardiovascular Device | ||||||
| 01/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: DIABETES | ||||||
| 11/28/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/02/2023 | Philips Electronics North America Corporation | (5050) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Medical Device | ||||||
| 10/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/13/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $48.68 | General |
| Category: Cardiovascular Device | ||||||
| 10/13/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: DIABETES | ||||||
| 10/09/2023 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $84.47 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/27/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: DIABETES | ||||||
| 08/24/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Medical Device | ||||||
| 08/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: DIABETES | ||||||
| 08/18/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Cardio-renal | ||||||
| 07/27/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiology | ||||||
| 07/10/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/16/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Medical Device | ||||||
| 06/15/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Genetic Disease | ||||||
| 05/19/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Cardiovascular | ||||||
| 05/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,494 | 2,226 | $496,379 | $187,442 |
| 2022 | 19 | 1,750 | 3,183 | $509,242 | $179,825 |
| 2021 | 17 | 1,622 | 2,323 | $400,826 | $158,049 |
| 2020 | 20 | 1,612 | 2,206 | $399,237 | $151,780 |
Total Patients
6,478
Total Services
9,938
Medicare Billing
$677,097
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 426 | $110,564 | $38,570 | 34.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 50 | 100 | $80,000 | $35,169 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 135 | 244 | $48,873 | $22,867 | 46.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 54 | 54 | $38,962 | $17,925 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 116 | 121 | $47,025 | $16,200 | 34.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 90 | 93 | $37,893 | $12,671 | 33.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 124 | $17,268 | $7,767 | 45.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 157 | 158 | $22,814 | $7,666 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,238 | $4,555 | 37.2% |
| 93245 | Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | Office | 2023 | 20 | 20 | $7,000 | $4,001 | 57.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $7,841 | $3,387 | 43.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 194 | 302 | $12,605 | $3,111 | 24.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 23 | 23 | $10,764 | $3,076 | 28.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 62 | 64 | $13,798 | $3,024 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 27 | $7,561 | $2,000 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $7,915 | $1,932 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 29 | $3,728 | $1,395 | 37.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 123 | 151 | $2,754 | $960.00 | 34.9% |
| J1245 | Injection, dipyridamole, per 10 mg | Office | 2023 | 40 | 163 | $2,964 | $480.43 | 16.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 14 | $2,584 | $270.90 | 10.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $613.44 | $196.20 | 32.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $402.48 | $130.32 | 32.4% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 14 | 14 | $210.00 | $86.62 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 396 | $84,613 | $35,400 | 41.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 163 | 320 | $64,096 | $25,525 | 39.8% |
About Dr. Bipul Roy, M.D
Dr. Bipul Roy, M.D is a Cardiovascular Disease healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1659539997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bipul Roy, M.D has received a total of $3,477 in payments from pharmaceutical and medical device companies, with $122.87 received in 2024. These payments were reported across 183 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,267).
As a Medicare-enrolled provider, Roy has provided services to 6,478 Medicare beneficiaries, totaling 9,938 services with total Medicare billing of $677,097. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Ocala, FL
- Active Since 05/22/2008
- Last Updated 02/01/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659539997
Products in Payments
- BRILINTA (Drug) $299.27
- ELIQUIS (Drug) $288.68
- LifeVest (Device) $270.75
- ENTRESTO (Drug) $216.03
- XARELTO (Drug) $205.61
- General - Therapies (Device) $168.14
- VYNDAQEL (Drug) $140.98
- JARDIANCE (Drug) $121.55
- Corlanor (Drug) $107.50
- Assure WCD (Device) $105.78
- WATCHMAN (Device) $88.93
- CONFIRM RX (Device) $84.47
- OPTIMIZER (Device) $81.40
- FARXIGA (Drug) $69.82
- Repatha (Biological) $65.68
- Optimizer (Device) $51.52
- CARDIOMEMS (Device) $50.87
- PRADAXA (Drug) $45.61
- ZIO XT Patch (Device) $43.68
- (5044) MCOT (Device) $38.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ocala
Dr. Celso Acevedo, Md, MD
Cardiovascular Disease — Payments: $162,222
Cardiovascular Disease $162,222
Dr. Lan Luo, Md, MD
Cardiovascular Disease — Payments: $79,241
Cardiovascular Disease $79,241
Hiroko Beck, Md, MD
Cardiovascular Disease — Payments: $46,884
Cardiovascular Disease $46,884
Dr. Siva Gummadi, M.d, M.D
Cardiovascular Disease — Payments: $32,776
Cardiovascular Disease $32,776
Dr. Gregory Vonmering, Md, MD
Cardiovascular Disease — Payments: $28,465
Cardiovascular Disease $28,465
Dr. Kalpesh Solanki, Do, DO
Cardiovascular Disease — Payments: $25,966
Cardiovascular Disease $25,966